Ignite Creation Date:
2024-10-25 @ 7:52 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06512441
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-16
Brief Title:
Vitamin B6 Aids in Treating Inflammatory Bowel Disease
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Vitamin B6 Assists in the Treatment of Inflammatory Bowel Disease
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Patients with IBD are randomized to oral administration of VitaminB6 and placebo based on the standard treatment exploring whether VitaminB6 can increasee the clinical remission rateand improve the treatment effect of IBD patients
Detailed Description:
Inflammatory bowel disease IBD is a group of chronic idiopathic inflammatory intestinal diseases mainly including ulcerative colitis and Crohns disease with increasing incidence in China and worldwide The disease currently lacks a cure with many patients experiencing relapses and requiring surgery and an increased risk of cancer There is substantial evidence suggesting a close relationship between body vitamin B6 levels and IBDThuswe design this clinical trial that aims to explore whether VitaminB6 can increasee the clinical remission rateand improve the treatment effect
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None